A Quantitative Process for Enhancing End of Phase 2 Decisions. (2014)

First Author: Sabin T
Attributed to:  MRC Clinical Trials Unit as the London Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/19466315.2013.852617

PubMed Identifier: 24683441

Publication URI: http://europepmc.org/abstract/MED/24683441

Type: Journal Article/Review

Volume: 6

Parent Publication: Statistics in biopharmaceutical research

Issue: 1

ISSN: 1946-6315